.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
UBS
Mallinckrodt
Argus Health
Colorcon
Daiichi Sankyo
US Army
Citi
Dow
McKesson

Generated: November 18, 2017

DrugPatentWatch Database Preview

OMNICEF Drug Profile

« Back to Dashboard

What is the patent landscape for Omnicef, and when can generic versions of Omnicef launch?

Omnicef is a drug marketed by Abbvie and is included in two NDAs.

The generic ingredient in OMNICEF is cefdinir. There are twelve drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the cefdinir profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
OMNICEF
cefdinir
CAPSULE;ORAL050739-001Dec 4, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbvie
OMNICEF
cefdinir
FOR SUSPENSION;ORAL050749-001Dec 4, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbvie
OMNICEF
cefdinir
FOR SUSPENSION;ORAL050749-002Jul 29, 2004DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OMNICEF

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
OMNICEF
cefdinir
CAPSULE;ORAL050739-001Dec 4, 1997► Subscribe► Subscribe
Abbvie
OMNICEF
cefdinir
FOR SUSPENSION;ORAL050749-002Jul 29, 2004► Subscribe► Subscribe
Abbvie
OMNICEF
cefdinir
FOR SUSPENSION;ORAL050749-001Dec 4, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Farmers Insurance
QuintilesIMS
Deloitte
Fish and Richardson
Cipla
US Army
Covington
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot